Patent details

Basic Information

Publication number:

EP3747880

PCT Application Number:

CN2018124418

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP189022122

PCT Publication Number:

WO2019144759

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTAL FORM TARGETING CDK4/6 KINASE INHIBITOR

French Title of Invention:

FORME CRISTALLINE CIBLANT UN INHIBITEUR DE KINASE CDK4/6

German Title of Invention:

KRISTALLFORM ZUM TARGETING VON CDK4/6-KINASE-INHIBITOREN

SPC Number:

Dates

Filing date:

27/12/2018

Grant date:

03/05/2023

EP Publication Date:

09/12/2020

PCT Publication Date:

01/08/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/05/2023

EP B1 Publication Date:

03/05/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/12/2023

Expiration date:

27/12/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/04/2023

 

 

Name:

Xuanzhu Biopharmaceutical Co., Ltd.

Address:

Beijing-Tianjin-Hebei Collaborative Innovation Demonstration Park 203C507 No.769 Taihang Street High-tech District, Shijiazhuang, Hebei Province, China (CN)

Inventor

1

Name:

FANG, Lan

Address:

China (CN)

2

Name:

FENG, Yuzhen

Address:

China (CN)

Priority

Priority Number:

201810084351

Priority Date:

29/01/2018

Priority Country:

China (CN)

Classification

IPC classification:

C07D 401/14; A61K 31/506; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:

202318

Publication date:

03/05/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages